Home
Search
Search Results
Previously Searched
3107 results found
Expand All
Apply All
3107 results found

“This is the time for us to talk about the science”
Good Day BIO Newsletter  •  December 16, 2020
COVID-19 vaccines are here—but how do we ensure people will get them when it’s their turn? BIO’s Dr. Michelle McMurry-Heath discussed this on CNN. Meanwhile, 2021 is shaping up to be a critical year in the war on climate change, so we take a look at the many ways gene editing can contribute. (834 words, 4 minutes, 10 seconds)
Read More

COVID-19 vaccines are here—but future innovation is at risk
Good Day BIO Newsletter  •  December 15, 2020
The emergency use authorization of a COVID-19 vaccine less than one year after the virus was identified is an amazing feat—but attempts to weaken IP protections could undermine this kind of innovation in the future. We explain why, plus look at how one company is successfully marketing its GM apples to consumers. (871 words, 4 minutes, 20 seconds)
Read More

Technology Transfer
Policy

Happy 40th, Bayh-Dole!
Good Day BIO Newsletter  •  December 14, 2020
It’s a happy Monday indeed with Pfizer-BioNTech vaccine doses on their way to every U.S. state and territory. Meanwhile, ICYMI in the midst of all the vaccine excitement, Bayh-Dole turned 40 and Congress passed the defense spending bill with a boost for the bioeconomy. (1,000 words, 5 minutes)
Read More

FDA panel recommends authorization of Pfizer-BioNTech vaccine
Good Day BIO Newsletter  •  December 11, 2020
It’s Friday. Congress is working to avoid a government shutdown today. Meanwhile, we have a recap of yesterday’s FDA advisory committee meeting on the Pfizer-BioNTech vaccine as well as details of a new group working to advance Black professionals in the agriculture industry. (727 words, 3 minutes, 38 seconds)
Read More

What to know ahead of FDA’s Pfizer/BioNTech meeting
Good Day BIO Newsletter  •  December 10, 2020
We preview today’s FDA meeting about the Pfizer/BioNTech COVID-19 vaccine. And believe it or not, the holiday season is here. If you still have some shopping to do, we give you ideas for sustainable, biobased gifts for everyone on your list. (863 words, 4 minutes, 18 seconds)
Read More

BIO Submits Comments on Final EPA PIP rule
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  December 9, 2020
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on proposed revisions to regulations related to the oversight of certain plant-incorporated protectants (PIPs).1 In particular, EPA’s proposed revisions would create an exemption from certain requirements of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Federal Food, Drug, and Cosmetic Act (FFDCA) for PIPs based upon sexually compatible plants developed using biotechnology.    
Read More

This bill would boost renewable chemicals and build resilience
Good Day BIO Newsletter  •  December 9, 2020
Today, we applaud a new bill that would boost renewable chemicals and the bioeconomy and explain why it’s not too late to get a flu vaccine. (724 words, 3 minutes, 37 seconds)
Read More

BIO challenges “Most Favored Nation” drug pricing plan
Good Day BIO Newsletter  •  December 8, 2020
It’s another busy day in Washington. In the meantime, we have details on our legal challenge to the Trump administration’s drug pricing plan, as well as a look at a new report on the health impacts of climate change and how sustainable biobased fuels can help. (850 words, 4 minutes, 15 seconds)
Read More

CDC’s COVID vaccine chief: no safety corners cut
Good Day BIO Newsletter  •  December 7, 2020
It’s a busy Monday. BIO’s Dr. Michelle McMurry-Heath talked with the CDC’s Dr. Nancy Messonnier about the safety and efficacy of the COVID-19 vaccines. Also, we look at the House leadership selections that will impact climate and the bioeconomy, including some historic “firsts.” (900 words, 4 minutes, 30 seconds)
Read More